SEC Form 4 · accession 0001424422-16-000017
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Morlock
Director
Period of report
Jan 11, 2016
Accepted (ET)
Jan 12, 2016 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jan 11, 2016 | P | 3,000 | $1.43 | A | 236,071 | I | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
| Common stockF1 | Jan 12, 2016 | P | 3,000 | $1.63 | A | 239,071 | I | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03